drugset / Trial / NCT01812057
Dexamethasone for Post-cesarean Delivery Pain
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to compare post-cesarean section consumption of pain medication between two groups of patients undergoing scheduled cesarean section at term gestation who receive a single-dose of intraoperative steroid (dexamethasone 8 milligrams) versus placebo at 24 hours after surgery. The hypothesis is that a single perioperative dose of dexamethasone 8 mg will significantly reduce postoperative opioid consumption at 24 h in women having cesarean delivery under spinal anesthesia.
Timeline
- Start
- 2012-12
- Primary completion
- 2016-05-27
- Completion
- 2016-09-21
Outcome
Missed primary endpoint
registry analysis (superiority test); Dexamethasone vs Placebo; p = 0.740; Wilcoxon (Mann-Whitney) NCT01812057 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 8 mg | Intravenous |